V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005980 | 280003722 | 1.77 | 87 | Palliative (P) | 2013-03-21 | 2013-03-21 | GemCarbo Days 1+8 | 02 | N | 280030067 | TRABECTEDIN |
| 280005981 | 280003723 | 1.77 | null | Palliative (P) | 2014-09-02 | 2014-09-02 | Gemcitabine 1000mg/m2 D1 8 15 | Y | null | 280030069 | PEMBROLIZUMAB |
| 280005982 | 280003723 | 1.59 | 79.9 | Disease modification (D) | 2018-01-17 | 2018-02-02 | BEP 5 Day | 02 | N | 280030069 | PACLITAXEL |
| 280005983 | 280003724 | 1.49 | 52 | Palliative (P) | 2018-01-09 | 2018-01-24 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280030071 | PACLITAXEL |
| 280005984 | 280003725 | 1.74 | 82.5 | Disease modification (D) | 2014-01-10 | 2014-09-20 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280030072 | TCF |
| 280005985 | 280003725 | 1.65 | 84.7 | Palliative (P) | 2015-10-24 | 2015-10-29 | DE-ESCALATE TRIAL | 02 | N | 280030072 | CAV |
| 280005986 | 280003726 | 1.74 | 69.3 | Palliative (P) | 2016-01-27 | 2016-01-27 | Irinotecan + Modified De Gramont | 2 | N | 280030074 | DOCETAXEL + GEMCITABINE |
| 280005987 | 280003727 | 1.6 | 61.4 | Neo-adjuvant (N) | 2017-04-17 | 2017-04-18 | CEDIRANIB | N | N | 280030079 | EURO-EWING |
| 280005988 | 280003728 | 1.68 | null | Palliative (P) | 2014-03-02 | 2014-03-30 | ECX | N | N | 280030080 | DOXORUBICIN + OLARATUMAB |
| 280005989 | 280003729 | 1.79 | 72.5 | Palliative (P) | 2013-08-17 | 2013-08-31 | CARBOPLATIN + GEMCITABINE | 02 | N | 280030081 | GEDDIS TRIAL |
| 280005990 | 280003729 | 1.6 | 81 | Curative (C) | 2016-11-11 | 2016-11-16 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE | N | N | 280030081 | RMS 2005 TRIAL |
| 280005991 | 280010069 | null | 99.8 | Palliative (P) | null | 2015-01-14 | CETUXIMAB + CISPLATIN + FU | N | N | 280030087 | DOCETAXEL + GEMCITABINE |
| 280005992 | 280010069 | 1.68 | 0 | Neo-adjuvant (N) | 2017-03-20 | 2017-04-08 | AXITINIB | N | N | 280030087 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280005993 | 280003730 | 1.71 | 75 | Adjuvant (A) | 2016-12-28 | 2016-12-29 | CAPECITABINE + CARBOPLATIN | N | N | 280030089 | CAPECITABINE |
| 280005994 | 280003730 | 0 | null | Curative (C) | 2014-07-01 | 2014-07-11 | STS Rhabdo Rel BERNIE IVADo | N | N | 280030089 | CISPLATIN + FLUOROURACIL + RT |
| 280005995 | 280003731 | 1.65 | 60 | Curative (C) | 2013-05-23 | 2013-06-05 | PEMBROLIZUMAB | 02 | N | 280030094 | RMS 2005 TRIAL |
| 280005996 | 280003732 | 1.71 | 68 | Palliative (P) | 2016-05-04 | 2016-05-19 | Chlorambucil | N | N | 280030095 | PAZOPANIB |
| 280005998 | 280003733 | 1.92 | 0 | Disease modification (D) | 2016-11-24 | 2016-11-25 | Gemcitabine weekly | N | N | 280030097 | CARBO + FLUOROURACIL |
| 280005999 | 280008015 | 1.58 | null | Neo-adjuvant (N) | null | 2017-04-07 | Carboplatin + Pemetrexed | null | null | 280030099 | VAI |
| 280006000 | 280003734 | 1.76 | 112.2 | Neo-adjuvant (N) | 2015-11-18 | 2015-11-19 | Fluorouricil + Folonic Acid (MdG) | 02 | null | 280030100 | VIDE |
| 280006001 | 280008016 | null | 56.1 | Neo-adjuvant (N) | 2013-12-06 | 2013-12-22 | Gemcitabine weekly | N | N | 280030101 | CARBOPLATIN + VINORELBINE |
| 280006002 | 280003735 | 1.79 | null | Disease modification (D) | 2014-10-01 | 2014-10-08 | VAI (Ifos 3g/m2) | 2 | N | 280030103 | CARBO + FLUOROURACIL |
| 280006003 | 280008017 | 1.83 | 76.2 | Palliative (P) | 2016-12-03 | 2016-12-21 | Capecitabine + Mitomycin | N | N | 280030105 | LIPOSOMAL DOXORUBICIN |
| 280006004 | 280010070 | 1.65 | 70 | Palliative (P) | null | 2014-06-19 | EW EuroEwing 99 : VIDE | 02 | null | 280030106 | DOXORUBICIN + OLARATUMAB |
| 280006005 | 280003736 | null | null | Palliative (P) | 2013-09-17 | 2013-09-19 | Paclitaxel 7 day | N | N | 280030107 | DOCETAXEL + GEMCITABINE |
| 280006006 | 280003737 | 1.51 | 86.8 | Palliative (P) | null | 2015-03-28 | Carboplatin + Liposomal Doxorubicin | N | null | 280030113 | CYCLOPHOSPHAMIDE |
| 280006007 | 280003737 | 1.72 | 48.5 | Neo-adjuvant (N) | 2016-09-09 | 2016-09-09 | Dacarbazine | Y | N | 280030113 | EURO-EWING |
| 280006008 | 280010071 | 1.73 | 27 | Neo-adjuvant (N) | 2016-01-06 | 2016-01-08 | IDELALISIB | N | N | 280030116 | CAPECITABINE + RT |
| 280006009 | 280010071 | 1.56 | 74.8 | Not known (9) | 2015-05-26 | 2015-05-26 | Cisplatin + Pemetrexed | 1 | N | 280030116 | TCF |
| 280006010 | 280010071 | 1.74 | 58.9 | Palliative (P) | 2013-08-03 | 2013-09-18 | Carboplatin + Pemetrexed | N | N | 280030116 | TRABECTEDIN |
| 280006011 | 280010071 | 1.87 | 108.4 | Palliative (P) | 2013-12-27 | 2013-12-30 | GemCarbo Days 1+8 | N | N | 280030116 | EPIRUBICIN |
| 280006012 | 280003738 | 1.59 | 67.7 | Curative (C) | 2018-02-02 | 2018-02-03 | Paclitaxel 7 day | N | N | 280030121 | DE-ESCALATE TRIAL |
| 280006013 | 280003738 | 1.61 | 76.8 | Curative (C) | 2015-03-09 | 2015-03-10 | Cisplatin + Doxorubicin | null | null | 280030121 | CARBO + FLUOROURACIL |
| 280006014 | 280003739 | 1.73 | 98.7 | Palliative (P) | 2017-11-27 | 2017-11-29 | FCiSt | N | N | 280030124 | DOCETAXEL |
| 280006015 | 280003739 | 1.7 | 70.1 | Curative (C) | 2017-03-29 | 2017-04-10 | Obinutuzumab | Y | N | 280030124 | IVA |
| 280006016 | 280003740 | 1.83 | 46.6 | Palliative (P) | 2016-02-05 | 2016-02-22 | Doxorubicin + Olaratumab | 02 | N | 280030127 | BRENTUXIMAB |
| 280006017 | 280008021 | 1.57 | 49 | Curative (C) | 2013-03-10 | 2013-03-23 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280030129 | IVADO |
| 280006018 | 280008021 | 1.65 | 73 | Neo-adjuvant (N) | 2015-01-16 | 2015-02-07 | GemCarbo Days 1+8 | N | N | 280030129 | BCG |
| 280006019 | 280003741 | 1.8 | 78.6 | Palliative (P) | 2016-03-14 | 2016-03-15 | Doxorubicin + Olaratumab | 02 | N | 280030132 | PACLITAXEL |
| 280006020 | 280003741 | null | 80.5 | Palliative (P) | 2017-11-25 | 2018-01-04 | DOCETAXEL + GEMCITABINE | N | Y | 280030132 | DOXORUBICIN + OLARATUMAB |
| 280006021 | 280003742 | 1.69 | 83 | Palliative (P) | 2016-10-28 | 2016-10-29 | STS Rhabdo RMS 2005 Vin Cyclo | N | null | 280030134 | TRABECTEDIN |
| 280006022 | 280003742 | 1.84 | 83.1 | Palliative (P) | 2015-09-12 | 2015-09-15 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280030134 | LANREOTIDE |
| 280006023 | 280003742 | 1.72 | 69.5 | Palliative (P) | 2017-03-12 | 2017-03-12 | Paclitaxel 7 day | 02 | N | 280030134 | DOXORUBICIN + OLARATUMAB |
| 280006024 | 280003743 | 1.73 | null | Neo-adjuvant (N) | 2017-06-03 | 2017-06-13 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280030137 | VIDE |
| 280006025 | 280003743 | null | null | Curative (C) | 2013-03-24 | 2013-04-04 | GemCarbo Days 1+8 | 2 | N | 280030137 | CISPLATIN + ETOPOSIDE |
| 280006026 | 280003743 | 1.77 | 65.6 | Palliative (P) | 2014-10-09 | 2015-06-19 | Cisplatin + Doxorubicin | N | N | 280030137 | CARBOPLATIN + PEMETREXED |
| 280006027 | 280003743 | 1.76 | 91.6 | Palliative (P) | 2017-11-17 | 2017-11-24 | GEMCARBO | 02 | N | 280030137 | PACLITAXEL |
| 280006028 | 280003744 | null | 86.8 | Curative (C) | 2017-08-24 | 2017-09-05 | PEMBROLIZUMAB | 2 | Y | 280030145 | EURO-EWING |
| 280006029 | 280008025 | 1.78 | 110 | null | null | 2017-07-13 | OCTREOTIDE | N | N | 280030146 | IFOSFAMIDE |
| 280006030 | 280008025 | 1.85 | null | Curative (C) | 2014-05-14 | 2014-05-15 | FEC 100 | N | N | 280030146 | DARS TRIAL |